Pharmaceutical Drug Delivery Market Report 2022-2027: Key Company Analysis, Trends, Growth, Size and Forecast

The latest research studyPharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the pharmaceutical drug delivery market size reached US$1,242.8 billion in 2021. Looking ahead, IMARC Group expects the market to reach a value of US$1,753.9 billion by 2027, showing a CAGR of 5.70% over the period 2022-2027.

What is Pharmaceutical Drug Delivery? What is the size of the Pharmaceutical Drug Delivery market?

Pharmaceutical drug delivery represents a method of delivering therapeutic substances into the body. It improves safety, efficacy and patient experience by controlling when, how much and where drug is released. Currently, various types of pharmaceutical drug delivery systems are commonly available for the delivery of several therapeutic agents. For example, gels, liposomes, microspheres, prodrugs, cyclodextrins, etc., are some of the effective methods used for peptide and protein therapies. As such, they are widely used in hospitals, home care facilities, outpatient surgery centers, etc.

Request to get sample report: https://www.imarcgroup.com/pharmaceutical-drug-delivery-market/requestsample

Covid-19 scenario: As the novel coronavirus (COVID-19) crisis engulfs the world, we continuously monitor changes in markets, as well as industry consumer behaviors around the world and our estimates on the latest market trends and forecasts are made. after considering the impact of this pandemic.

Market Trends and Drivers:

The growing prevalence of respiratory diseases, leishmaniasis, central nervous system (CNS) disorders, systemic fungal infections, etc. is mainly driving the pharmaceutical drug delivery market. Additionally, increasing mortality rates among the geriatric population and those more susceptible to developing cancer are propelling the adoption of this method which offers increased efficacy and reduced toxicity for anti-cancer agents. In addition to this, the growing popularity of nanoparticles comprising biodegradable polymers to improve drug delivery to the brain acts as another important growth inducing factor.

Additionally, they also help meet requirements including biocompatibility, stability against forces generated during aerosolization, targeting specific sites or cell populations within the lungs, drug release in a predetermined manner , degradation within an acceptable time frame, etc., placed on these systems. by government agencies, increasing the global market. Apart from this, growing consumer inclination towards personalized and minimally invasive (MI) medical therapy is expected to drive the pharmaceutical drug delivery market during the forecast period.

Click here to view detailed information with table of contents: https://www.imarcgroup.com/pharmaceutical-drug-delivery-market

Pharmaceutical Drug Delivery Market Report scope

Report cover

Details

Market size value in 2021

US$1,242.8 billion

Market forecast in 2027

US$1,753.9 billion

Rate of growth

CAGR of 5.70% from 2022 to 2027

Base year for the estimate

2021

Historical data

2016-2021

Forecast period

2022-2027

Report cover

Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

Segments Covered

Route of administration, application, end user and region

Regional scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

Profiled Key Companies

AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi SA

Market dynamics

Parent Market Analysis, Market Growth Drivers and Barriers, Fast and Slow Growing Segment Analysis, COVID 19 Impact and Future Consumer Dynamics, Market Condition Analysis for the Forecast Period,

Customization overview

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Report segmentation:

The report has segmented the market into the following categories:

Distribution by route of administration:

Administration of oral medications

Administration of injectable drugs

Administration of topical medications

Ocular administration of drugs

Pulmonary administration of drugs

Administration of implantable drugs

Transmucosal administration of drugs

Nasal administration of drugs

Breakdown by application:

Infectious diseases

Cancer

Cardiovascular illnesses

Diabetes

Respiratory diseases

Central nervous system disorders

Autoimmune diseases

Others

Breakdown by end user:

Hospitals

Ambulatory surgery centers

Home care settings

Diagnostic centers

Others

By geography:

North America

oh United States

oh Canada

Asia Pacific

oh China

oh Japan

oh India

oh South Korea

oh Australia

oh Indonesia

oh Others

Europe

oh Germany

oh France

oh UK

oh Italy

oh Spain

oh Russia

oh Others

Latin America

oh Brazil

oh Mexico

oh Others

Middle East and Africa

List of major key players:

The major market players are AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi SA.

About Us:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Our offerings include comprehensive market information in the form of research reports, production cost reports, feasibility studies and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium-sized businesses to Fortune 1000 companies.

Contact us:

IMARC Services Private Limited.

30 N Gould St Ste R

Sheridan, Wyoming 82801 USA – Wyoming

E-mail: [email protected]

Such. :(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800